Ocuphire Pharma, Inc.   Report issue

For profit Phase 1 Phase 2 Phase 3
Founded: Farmington Hills MI United States (2018)
Status: Acquired by Rexahn Pharmaceuticals, Inc. (2020)

Organization Overview

First Clinical Trial
2018
NCT04004507
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Mergers & Acquisitions

Historical Acquisition Tree